Author

Paul L. Ollila

Observed name: Paul Ollila

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5025804537

Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis

2019 · Rong He, Daniel J. Devine, et al. · Modern Pathology · 35

Prevalence of Concurrent (Double‐Positive) JAK2 , CALR , or MPL Mutations and Corresponding Clinicopathologic Features: Analysis of 21556 Mayo Clinic NGS Studies Including 2651 Informative Cases

2025 · Rong He, Paul L. Ollila, et al. · American Journal of Hematology · 4

Low (0.1% to ≤ 1%) or Very Low (0.06% to < 0.1%) JAK2 V617F Allele Burden in Routine Testing: Clinical Correlates and Clonal Trajectory

2025 · Ruah Alyamany, Ahmed Alnughmush, et al. · American Journal of Hematology · 1

Acute myeloid leukemia arising in treated chronic lymphocytic leukemia/small lymphocytic lymphoma: a challenge in analysis of lineage relationship

2026 · Aruna Rangan, Min Shi, et al. · Journal of Hematopathology

Correction to: Hybridization capture-based next-generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis

2019 · Rong He, Daniel J. Devine, et al. · Modern Pathology

Works count: 5

Citation count: 40

H-index: 2

I10-index: 1